TORIGEN PHARMACEUTICALS, INC. — Form D/A
TORIGEN PHARMACEUTICALS, INC. of FARMINGTON, CT, a company, filed a Form D amendment with the SEC on 2021-03-05. The offering totals $3.5M, of which $3.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-03-05
- Form: D/A
- Accession: 0001764961-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.3M
- Remaining: $228K
- Investors: 38
- Date of first sale: 2020-06-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-369063
Issuer
- Name: TORIGEN PHARMACEUTICALS, INC.
- CIK: 0001764961
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 FARMINGTON AVE., R1855 CB129, FARMINGTON, CT, 06032
- Phone: 860-519-9956
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Kevin Crowley | Director | Stamford, CT |
| Elizabeth Galbut | Director | Naples, FL |
| John Kallassy | Executive Officer | Farmington, CT |
| Blake Hawley | Director | Farmington, CT |
| Musan Duric | Director | Portland, ME |
| Ashley Kalinauskas | Director | Farmington, CT |
| Ashley Kalinauskas | Executive Officer | Farmington, CT |
| Mark Suckow | Director | Farmington, CT |
| Mark Suckow | Executive Officer | Farmington, CT |
| Brad Poff | Executive Officer | Farmington, CT |
| Terry Dew | Executive Officer | Farmington, CT |
Other filings by this issuer (4)
More